capromab-pendetide has been researched along with Lymphoma--B-Cell* in 1 studies
1 other study(ies) available for capromab-pendetide and Lymphoma--B-Cell
Article | Year |
---|---|
Detection of a non-Hodgkin's lymphoma by capromab pendetide scintigraphy (ProstaScint) in a patient with prostate carcinoma.
A 77-year-old man with Gleason score 7 prostate cancer, after radical prostatectomy, in whom the prostate-specific antigen level increased to 5.0 ng/mL 8 years later, underwent a ProstaScint scan. Radiotracer deposition was noted in the prostatic "fossa," highly suspicious of recurrence. An additional focus in the mid abdomen was suspicious of adenopathy. Computed tomography disclosed an abdominal mass that, at biopsy, proved to be a malignant B-cell lymphoma. That lesion resolved after chemotherapy, and the prostate-specific antigen level substantially decreased with hormonal treatment. The possible association of prostate cancer and lymphoma is discussed. Topics: Aged; Antibodies, Monoclonal; Humans; Lymphatic Metastasis; Lymphoma, B-Cell; Male; Neoplasms, Multiple Primary; Radioimmunodetection | 2002 |